Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Yvoir
Clinical trial register · Belgium

Clinical Trials in Yvoir, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3055 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
3055
Studies in scope
all four open statuses
1723
Recruiting now
open to new participants
505
Lead sponsors
across recruiting studies
Top sites
Leuven 1275 Brussels 1118 Ghent 1030 Liège 562 Edegem 441
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The Lymphoma Academic Research Organisation8 Merck Sharp & Dohme LLC7 Bristol-Myers Squibb7 University Hospital of Mont-Godinne7 AbbVie6 Janssen Research & Development, LLC6 Sanofi5 Pfizer5 Novartis Pharmaceuticals4 Eli Lilly and Company4 European Organisation for Research and Treatment of Cancer - EORTC4 Acerta Pharma BV4 AstraZeneca4 Amgen4 Takeda3 Genmab3 Boehringer Ingelheim3 Intergroupe Francophone du Myelome3 Incyte Corporation2 Mirati Therapeutics Inc.2 Centre Hospitalier Universitaire UCLouvain Namur2 BeOne Medicines2 Abivax S.A.2 Biohaven Therapeutics Ltd.2 Celgene2 Show all 70
Site location
Leuven1275 Brussels1118 Ghent1030 Liège562 Edegem441 Antwerp290 Bruges263 Roeselare249 Hasselt215 Aalst185 Kortrijk183 Charleroi175 Genk174 Anderlecht167 Yvoir153 Namur138 Jette128 Sint-Niklaas116 Bonheiden101 Wilrijk75 Brasschaat72 Mechelen61 La Louvière59 Woluwe-Saint-Lambert57 Ottignies48 Show all 205
All 205 locations
Target enrolment
to

Trials with a site in Yvoir

153 of 3055 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Yvoir, Leuven, Brussels, Kortrijk, Liège
2026-12-16
Recruiting
Takeda
Phase 3
324
La Louvière, Leuven, Roeselare, Antwerp, Yvoir
2026-09-10
Recruiting
Inter-Limb Transfer in Acute Stroke
NCT07822633Stroke, Acute, Stroke (Subacute), Healthy Individuals (Controls), Chronic Stroke Patients
University Hospital of Mont-Godinne
Not applicable
250
Yvoir, Brussels
2026-08-11
Recruiting
Boehringer Ingelheim
Phase 3
448
Brussels, Ghent, Jette, Leuven, Liège, Yvoir
2026-07-27
Recruiting
AbbVie
Phase 3
990
Bonheiden, Edegem, Anderlecht, Brussels, Jette, Charleroi, Yvoir, Ghent
2026-05-22
Recruiting
Takeda
Phase 3
300
Yvoir, Leuven, Roeselare
2026-05-21
Recruiting
Unimanual Versus Bimanual Motor Skill Learning in Acute and Chronic Stroke
NCT07826832Acute Stroke, Chronic Stroke Patient, Healthy Individuals (Controls), Stroke (Subacute)
University Hospital of Mont-Godinne
Not applicable
200
Yvoir
2026-05-18
Recruiting
Incyte Corporation
Phase 3
588
Anderlecht, Brussels, Edegem, Ghent, Gilly, Leuven, Liège, Yvoir
2026-04-09
Recruiting
Incyte Corporation
Phase 3
700
Brussels, Edegem, Ghent, Leuven, Yvoir
2026-03-05
Recruiting
Eli Lilly and Company
Phase 3
300
Brussels, Edegem, Ghent, Leuven, Liège, Namur, Yvoir
2026-02-05
Recruiting
Ziekenhuis Oost-Limburg
Phase 4
306
Aalst, Brussels, Genk, Kortrijk, Leuven, Lodelinsart, Yvoir
2026-01-27
Active, closed
CSL Behring
Phase 2
84
Ghent, Edegem, Jette, Liège, Yvoir
2026-01-22
Recruiting
Sanofi
Phase 3
751
Yvoir
2026-01-22
Recruiting
Sanofi
Phase 3
751
Yvoir
2026-01-16
Recruiting
Contineum Therapeutics
Phase 2
324
Brussels, Yvoir
2026-01-08
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Edegem, Yvoir, Roeselare, Brussels, Liège
2026-01-02
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Edegem, Ghent, Hasselt, Jette, Kortrijk, Libramont, Yvoir
2025-11-30
Recruiting
Amgen
Phase 3
750
Brussels, Ghent, Kortrijk, Leuven, Yvoir
2025-11-28
Active, closed
Boehringer Ingelheim
Phase 2
81
Brussels, Yvoir
2025-11-13
Recruiting
AstraZeneca
Phase 3
420
Antwerp, Brussels, Ghent, Leuven, Roeselare, Yvoir
2025-11-11
Recruiting
Bristol-Myers Squibb
Phase 2/3
500
Wilrijk, Auderghem, Yvoir, Ghent, Sint-Niklaas
2025-11-05
Recruiting
AstraZeneca
Phase 3
400
Hasselt, La Louvière, Libramont-Chevigny, Sint-Niklaas, Yvoir
2025-10-31
Recruiting
Sanofi
Phase 3
980
Genk, Liège, Sint-Niklaas, Yvoir
2025-10-01
Recruiting
Sanofi
Phase 3
942
Brussels, Edegem, Erpent, Leuven, Mechelen, Yvoir
2025-09-16
Recruiting
BeOne Medicines
Phase 3
500
Anderlecht, Ghent, Kortrijk, Liège, Mechelen, Yvoir
2025-09-04
Recruiting
Basilea Pharmaceutica
Phase 3
234
Bruges, Charleroi, Hasselt, Leuven, Yvoir
2025-08-26
Active, closed
Amgen
Phase 3
350
Hasselt, Leuven, Roeselare, Yvoir
2025-08-18
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Antwerp, Brussels, Ghent, Leuven, Liège, Yvoir
2025-08-05
Recruiting
Intergroupe Francophone du Myelome
Phase 3
824
Brussels, Charleroi, Liège, Yvoir
2025-07-09
Active, closed
Mundipharma Research Limited
Phase 2
60
Brussels, Ghent, Leuven, Yvoir
2025-06-30
Recruiting
Eikon Therapeutics
Phase 2/3
740
Edegem, Brussels, Yvoir, Leuven, Kortrijk, Sint-Niklaas
2025-05-22
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Antwerp, Bruges, Brussels, Ghent, Hasselt, Leuven, Liège, Yvoir
2025-05-05
Recruiting
The Dragon PLC Trial (DRAGON-PLC)
NCT06914648Primary Liver Cancer, Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Maastricht University
Not applicable
358
Brussels, Antwerp, Ghent, Liège, Yvoir, Hasselt, Jette, Kortrijk
2025-04-01
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Edegem, Brussels, Yvoir, Ghent
2025-03-12
Active, closed
Takeda
Observational
66
Anderlecht, Brussels, Edegem, Ghent, Jette, Leuven, Liège, Yvoir
2025-02-24
Recruiting
The Lymphoma Academic Research Organisation
Phase 2
100
Bruges, Brussels, Liège, Yvoir
2025-02-21
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
136
Brussels, Haine-Saint-Paul, Yvoir
2025-01-14
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Genk, Ghent, Leuven, Yvoir
2024-12-16
Recruiting
Basilea Pharmaceutica
Phase 3
450
Bruges, Brussels, Hasselt, Leuven, Yvoir
2024-12-11
Active, closed
Vicore Pharma AB
Phase 2
378
Brussels, Liège, Yvoir
2024-12-09
Recruiting
Study on the Clinical Efficacy of Teclistamab and Talquetamab
NCT06477783Multiple Myeloma, Hematologic Diseases
DrugTeclistamab
Universitaire Ziekenhuizen KU Leuven
Observational
100
Bonheiden, Edegem, Charleroi, Hornu, Mons, Hasselt, Liège, Yvoir
2024-12-01
Active, closed
Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.
NCT06584513Benzodiazepines Deprescribing, Sleep Problems
Insel Gruppe AG, University Hospital Bern
Not applicable
470
Yvoir
2024-11-18
Recruiting
Abivax S.A.
Phase 2
212
Brussels, Ghent, Leuven, Tournai, Yvoir
2024-10-30
Recruiting
Salubris Biotherapeutics Inc
Phase 1/2
255
Antwerp, Brussels, Ghent, Yvoir
2024-10-23
Active, closed
Eli Lilly and Company
Phase 2
143
La Louvière, Yvoir
2024-10-10
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Edegem, Brussels, Hasselt, Yvoir, Roeselare, Liège
2024-10-07
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Antwerp, Brussels, Ghent, Leuven, Liège, Yvoir
2024-09-26
Recruiting
AbbVie
Phase 2
590
Bonheiden, Anderlecht, Brussels, Liège, Yvoir, Leuven, Kortrijk, Ostend
2024-09-04
Active, closed
Genmab
Phase 3
379
Jette, Boussu, Yvoir, Leuven, Roeselare
2024-08-13
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Edegem, Anderlecht, Brussels, Yvoir, Ghent
2024-07-30
Active, closed
The Lymphoma Academic Research Organisation
Phase 3
790
Bruges, Brussels, Charleroi, Ghent, La Louvière, Liège, Yvoir
2024-06-07
Active, closed
Amgen
Phase 3
563
Aalst, Brussels, Edegem, Genk, Ghent, Mons, Yvoir
2024-06-05
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Antwerp, Leuven, Liège, Roeselare, Yvoir
2024-06-03
Recruiting
Daiichi Sankyo
Phase 3
540
Brussels, Edegem, Hasselt, Liège, Roeselare, Yvoir
2024-05-21
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Aalst, Brugge (Bruges), Edegem, Gent (Ghent), Leuven, Sint-Niklaas, Yvoir
2024-04-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Edegem, Yvoir, Sint-Niklaas
2024-04-03
Recruiting
GlaxoSmithKline
Phase 3
864
Brussels, Charleroi, Edegem, Ghent, Liège, Yvoir
2024-03-21
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Edegem, Anderlecht, Brussels, Yvoir, Ghent
2024-03-14
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Genk, Yvoir, Aalst, Kortrijk, Roeselare
2024-03-07
Recruiting
Université Catholique de Louvain
Not applicable
3,900
Yvoir
2024-03-04
Recruiting
Pfizer
Phase 3
492
Brussels, Gilly, Hornu, Verviers, Yvoir
2024-02-08
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Anderlecht, Gilly, Kortrijk, Roeselare, Yvoir
2024-02-05
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Yvoir, Ghent, Roeselare, Antwerp, Brussels
2023-12-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Edegem, Yvoir, Aalst, Sint-Niklaas
2023-12-06
Recruiting
Charite University, Berlin, Germany
Not applicable
3,595
Aalst, Bruges, Liège, Yvoir
2023-11-16
Active, closed
Summit Therapeutics
Phase 3
1,600
Ronse, Yvoir
2023-10-26
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Yvoir, Leuven, Brussels, Kortrijk, Liège
2023-10-25
Recruiting
Sanofi
Phase 3
180
Leuven, Yvoir
2023-10-10
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Yvoir, Roeselare, Antwerp, Brussels
2023-09-18
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Yvoir, Brussels, Kortrijk, Leuven, Liège
2023-09-14
Recruiting
The Lymphoma Academic Research Organisation
Phase 3
260
Anderlecht, Brussels, Ghent, Yvoir
2023-09-05
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
Brussels, Ottignies, Yvoir
2023-07-22
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Bonheiden, Charleroi, Genk, La Louvière, Leuven, Liège, Namur, Yvoir
2023-04-25
Recruiting
Bimanual Motor Skill Learning in Acute Stroke
NCT05760846Stroke, Acute, Stroke, Subacute
University Hospital of Mont-Godinne
Not applicable
160
Yvoir
2023-04-17
Recruiting
AstraZeneca
Phase 3
4,300
Brussels, Edegem, Ghent, Leuven, Liège, Ottignies, Wilrijk, Yvoir
2023-03-31
Active, closed
AlgoTherapeutix
Phase 2
276
Aalst, Edegem, Ghent, Pellenberg, Yvoir
2023-02-28
Active, closed
Genmab
Phase 3
900
Antwerp, Brussels, La Louvière, Liège, Yvoir, Ghent, Sint-Niklaas, Leuven
2023-02-08
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Yvoir, Roeselare
2023-02-02
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Brussels, Ghent, Leuven, Liège, Roeselare, Yvoir
2023-01-16
Recruiting
AstraZeneca
Phase 3
3,527
Kortrijk, Ottignies, Roeselare, Yvoir
2022-12-13
Recruiting
Pfizer
Phase 3
1,060
Ottignies, Brussels, Gilly, Yvoir, Bruges, Roeselare
2022-11-10
Recruiting
The CATALINA Study
NCT05008081Chronic Obstructive Pulmonary Disease Exacerbation
Wim Janssens
Observational
1,000
Brussels, Leuven, Yvoir
2022-10-25
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Brussels, Edegem, Hasselt, Liège, Ottignies, Yvoir
2022-10-13
Recruiting
EMD Serono Research & Development Institute, Inc.
Observational
700
Hasselt, Roeselare, Sint-Niklaas, Yvoir
2022-10-04
Recruiting
University of Ulm
Phase 3
650
Antwerp, Bruges, Brussels, Leuven, Roeselare, Yvoir
2022-09-13
Recruiting
Universitaire Ziekenhuizen KU Leuven
Phase 4
292
Antwerp, Edegem, Brussels, Jette, Tournai, Genk, Liège, Yvoir
2022-09-08
By invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis
DrugTreprostinil
United Therapeutics
Phase 3
1,850
Anderlecht, Yvoir, Aalst, Antwerp, Brussels, Leuven, Liège
2022-09-06
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
Bonheiden, Brussels, La Louvière, Libramont, Yvoir, Aalst, Ghent, Kortrijk
2022-08-08
Active, closed
Novartis Pharmaceuticals
Phase 3
610
Turnhout, Genk, Hasselt, Yvoir, Aalst
2022-07-08
Recruiting
Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies
NCT05611515Supraglottic Squamous Cell Carcinoma, Early Stage (T1-T2, N0-N1,M0)
Centre Hospitalier Universitaire UCLouvain Namur
Observational
108
Yvoir
2022-06-17
Active, closed
ADC Therapeutics S.A.
Phase 1
154
Ghent, Yvoir
2022-06-17
Active, closed
Pierre Fabre Medicament
Phase 3
815
Anderlecht, Antwerp, Brussels, Ghent, Merksem, Sint-Niklaas, Yvoir
2022-05-02
Recruiting
The DRAGON 2 Trial
NCT05428735Colorectal Cancer Liver Metastases (CRLM), Small Future Liver Remnant (FLR)
Maastricht University
Not applicable
348
Brussels, Liège, Yvoir, Ghent
2022-04-01
Active, closed
Pfizer
Phase 3
854
Anderlecht, Charleroi, Yvoir, Ghent, Antwerp, Brussels
2022-03-25
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
210
Bruges, Brussels, Haine-Saint-Paul, Liège, Yvoir
2022-01-24
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
71
Brussels, Charleroi, La Louvière, Liège, Yvoir
2021-12-20
Active, closed
Eli Lilly and Company
Phase 3
152
Edegem, Brussels, Yvoir, Ottignies, Roeselare, Namur
2021-12-20
Active, closed
Intergroupe Francophone du Myelome
Phase 3
791
Brussels, Charleroi, Haine-Saint-Paul, Liège, Yvoir
2021-12-08
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Genk, Yvoir, Kortrijk, Roeselare, Antwerp, Brasschaat, Bruges, Brussels
2021-11-23
Active, closed
Janssen Pharmaceutica N.V., Belgium
Observational
256
Edegem, Genk, Leuven, Mons, Sint-Niklaas, Yvoir
2021-11-18
Recruiting
Pfizer
Phase 3
893
Gilly, Yvoir
2021-10-04
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Ghent, La Louvière, Yvoir
2021-09-20
Active, closed
University Hospital of Mont-Godinne
Not applicable
16
Yvoir
2021-09-07
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Brussels, Yvoir, Leuven, Roeselare
2021-06-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Brussels, Edegem, Ghent, Yvoir
2021-06-24
Active, closed
The Lymphoma Academic Research Organisation
Phase 2
141
Bruges, Ghent, Verviers, Yvoir
2021-06-11
Recruiting
Boston Scientific Corporation
Observational
12,500
Jette, Yvoir
2021-03-31
Active, closed
Celgene
Phase 3
313
Bruges, Brussels, Hasselt, Leuven, Liège, Roeselare, Verviers, Yvoir
2021-02-25
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Brussels, Edegem, Ghent, Gilly, Hasselt, Roeselare, Ronse, Yvoir
2021-02-23
Active, closed
University Hospital of Mont-Godinne
Not applicable
50
Yvoir
2021-01-29
Active, closed
Amgen
Phase 1/2
181
Yvoir
2021-01-04
Active, closed
Daiichi Sankyo
Phase 3
605
Haine-Saint-Paul, Libramont, Liège, Yvoir
2020-12-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Brussels, Gilly, Mons, Yvoir, Leuven, Roeselare
2020-12-08
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
68
Brussels, Edegem, Yvoir
2020-11-17
Active, closed
Genmab
Phase 1/2
543
Bruges, Ghent, Yvoir
2020-11-03
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Leuven, Roeselare, Yvoir
2020-10-13
Active, closed
AbbVie
Phase 3
531
Antwerp, Brussels, La Louvière, Yvoir, Ghent, Leuven, Bruges
2020-09-10
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
240
Yvoir, Antwerp, Edegem, Ghent, Haine-Saint-Paul
2020-08-20
Active, closed
GlaxoSmithKline
Phase 3
325
Bruges, Brussels, Edegem, Kortrijk, Yvoir
2020-04-02
Active, closed
Intergroupe Francophone du Myelome
Not applicable
395
Brussels, Yvoir
2020-02-11
Recruiting
University Hospital of Mont-Godinne
Not applicable
245
Yvoir
2020-01-01
Active, closed
Inotrem
Phase 2
355
Brussels, Genk, Ghent, La Louvière, Lodelinsart, Ottignies, Yvoir
2019-11-13
Not yet open
Centre Hospitalier Universitaire UCLouvain Namur
Observational
120
Namur, Yvoir
2019-11-01
Active, closed
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas
NCT03697512Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma
DrugsIbrutinib·Rituximab
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
175
Yvoir
2019-09-27
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Brussels, Pellenberg, Yvoir
2019-09-16
Active, closed
BeOne Medicines
Phase 3
510
Bruges, Brussels, Edegem, Kortrijk, Liège, Yvoir
2019-08-20
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Brussels, Ghent, Jette, Liège, Sint-Niklaas, Yvoir
2019-08-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
St-Lambrechts-Woluwe, Yvoir, Ghent, Leuven, Bruges, Roeselare
2019-07-24
Recruiting
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
NCT03852407Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes, Chronic Myeloid Leukemia in Remission, Myeloproliferative Syndrome
DrugsPTCy·Thymoglobulin·Cyclophosphamid·Melphalan
University of Liege
Phase 2
114
Antwerp, Bruges, Brussels, Ghent, Leuven, Liège, Roeselare, Yvoir
2019-02-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Bonheiden, Edegem, Anderlecht, Brussels, Liège, Hasselt, Yvoir, Ghent
2018-12-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Edegem, Yvoir, Aalst, Ghent
2018-12-24
Active, closed
AbbVie
Phase 3
1,242
Bonheiden, Anderlecht, Brussels, Liège, Yvoir, Leuven, Roeselare
2018-08-28
Active, closed
AbbVie
Phase 3
1,336
Bonheiden, Mechelen, Merksem, Anderlecht, Brussels, Liège, Yvoir, Ghent
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Aalst, Antwerp, Brussels, Charleroi, Ghent, Liège, Wilrijk, Yvoir
2018-03-23
Active, closed
AbbVie
Phase 3
747
Brussels, Yvoir, Ghent, Leuven, Liège
2018-03-21
Active, closed
Pfizer
Phase 3
1,054
Brasschaat, Ghent, Kortrijk, Ottignies, Yvoir
2017-12-18
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
61
Brussels, Ghent, Yvoir
2017-12-01
Active, closed
BeiGene
Phase 3
590
Brussels, Ghent, Liège, Ottignies, Yvoir
2017-10-31
Active, closed
Eli Lilly and Company
Phase 3
5,637
Brasschaat, Edegem, Brussels, Lodelinsart, Hasselt, Liège, Libramont, Yvoir
2017-07-12
Recruiting
University Hospital of Mont-Godinne
Not applicable
100
Yvoir
2017-07-01
Recruiting
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry
NCT04220970Anaplastic Large Cell Lymphoma Associated With Breast Implants (BIA-ALCL)
The Lymphoma Academic Research Organisation
Observational
150
Bruges, Brussels, Edegem, Ghent, Leuven, Liège, Yvoir
2017-06-07
Active, closed
Acerta Pharma BV
Phase 3
310
Antwerp, Ghent, Roeselare, Yvoir
2017-02-02
Active, closed
The Lymphoma Academic Research Organisation
Phase 1/2
214
Brussels, Liège, Yvoir
2016-10
Active, closed
Celgene
Phase 1/2
130
Yvoir
2016-06-03
Active, closed
Xcovery Holdings, Inc.
Phase 3
290
Yvoir
2016-06
Active, closed
Phase III Radium 223 mCRPC-PEACE III
NCT02194842Prostate Cancer
DrugsRa223·Enzalutamide
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
446
Brussels, Edegem, Kortrijk, Leuven, Turnhout, Yvoir
2015-10
Active, closed
Acerta Pharma BV
Phase 3
533
Bruges, Brussels, Ghent, Leuven, Yvoir
2015-07-28
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Yvoir, Ghent, Brussels
2015-07-14
Active, closed
Acerta Pharma BV
Phase 3
535
Bruges, Brussels, Ghent, Kortrijk, Leuven, Roeselare, Wilrijk, Yvoir
2015-06-26
Active, closed
Acerta Pharma BV
Phase 2
124
Bruges, Brussels, Liège, Yvoir
2015-03-02
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Antwerp, Bruges, Brussels, Ghent, Leuven, Yvoir
2013-09-09
Active, closed
Zwi Berneman
Phase 2
130
Antwerp, Brussels, Ghent, Liège, Roeselare, Yvoir
2012-10
Recruiting
Medtronic
Observational
20,000
Bruges, Brussels, Edegem, Leuven, Liège, Yvoir
1983-01
Rows per page Showing 1–153 of 153
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-belgium/city/yvoir

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,055 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 153 of those studies with a site in Yvoir.

How many clinical trials are recruiting in Yvoir?

70 of the 153 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 2 have not yet opened recruitment, 79 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Yvoir), 153 studies
PhaseStudiesRecruitingShare
Phase 3883957.5%
Phase 227817.6%
Not applicable1398.5%
Observational1177.2%
Phase 1/2613.9%
Phase 2/3543.3%
Phase 4221.3%
Phase 1100.7%

Most active sponsors

Lead sponsors with the most studies (Yvoir)
Lead sponsorStudiesRecruiting
The Lymphoma Academic Research Organisation83
Bristol-Myers Squibb74
Merck Sharp & Dohme LLC71
University Hospital of Mont-Godinne75
AbbVie62
Janssen Research & Development, LLC62
Pfizer53
Sanofi55
Acerta Pharma BV40
Amgen41
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.